Skip to content

Krystal Biotech, Inc.

KRYS

CIK 0001711279

← back to feed
Revenue (TTM)
$398.38M
+33.9% YoY Q1 Apr 2026
Net Income (TTM)
$209.36M
+129.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
$6.98
+128.0% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
42.8%
Q1 Apr 2026
Net Margin
52.6%
Q1 Apr 2026
Free Cash Flow (TTM)
$81.09M
Q1 Apr 2026
Cash
$501.31M
Q1 Apr 2026
Total Debt
$4.25M
Q1 Apr 2026
Shares Outstanding
29.48M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings